Effects of matrix metalloproteinase (MMP)-2 polymorphisms on responsiveness to antihypertensive therapy of women with hypertensive disorders of pregnancy (2012)
- Authors:
- USP affiliated authors: CAVALLI, RICARDO DE CARVALHO - FMRP ; LACCHINI, RICCARDO - FMRP ; DUARTE, GERALDO - FMRP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- DOI: 10.1111/j.1742-7843.2012.00905.x
- Subjects: HIPERTENSÃO (FARMACOLOGIA); METALOPROTEINASES; PRÉ-ECLÂMPSIA; GRAVIDEZ; REAÇÃO EM CADEIA POR POLIMERASE
- Language: Inglês
- Imprenta:
- Publisher place: West Sussex
- Date published: 2012
- Source:
- Título: Basic and Clinical Pharmacology and toxicology
- ISSN: 1742-7851
- Volume/Número/Paginação/Ano: v. 111, n. 4, p. 262-267, 2012
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
PALEI, Ana C. T. et al. Effects of matrix metalloproteinase (MMP)-2 polymorphisms on responsiveness to antihypertensive therapy of women with hypertensive disorders of pregnancy. Basic and Clinical Pharmacology and toxicology, v. 111, n. 4, p. 262-267, 2012Tradução . . Disponível em: https://doi.org/10.1111/j.1742-7843.2012.00905.x. Acesso em: 29 dez. 2025. -
APA
Palei, A. C. T., Sandrim, V. C., Amaral, L. M., Machado, J. S. R., Cavalli, R. de C., Lacchini, R., et al. (2012). Effects of matrix metalloproteinase (MMP)-2 polymorphisms on responsiveness to antihypertensive therapy of women with hypertensive disorders of pregnancy. Basic and Clinical Pharmacology and toxicology, 111( 4), 262-267. doi:10.1111/j.1742-7843.2012.00905.x -
NLM
Palei ACT, Sandrim VC, Amaral LM, Machado JSR, Cavalli R de C, Lacchini R, Duarte G, Santos JET dos. Effects of matrix metalloproteinase (MMP)-2 polymorphisms on responsiveness to antihypertensive therapy of women with hypertensive disorders of pregnancy [Internet]. Basic and Clinical Pharmacology and toxicology. 2012 ; 111( 4): 262-267.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1111/j.1742-7843.2012.00905.x -
Vancouver
Palei ACT, Sandrim VC, Amaral LM, Machado JSR, Cavalli R de C, Lacchini R, Duarte G, Santos JET dos. Effects of matrix metalloproteinase (MMP)-2 polymorphisms on responsiveness to antihypertensive therapy of women with hypertensive disorders of pregnancy [Internet]. Basic and Clinical Pharmacology and toxicology. 2012 ; 111( 4): 262-267.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1111/j.1742-7843.2012.00905.x - Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy
- Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy
- ENOS tagging SNP haplotypes in hypertensive disorders of pregnancy
- Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy
- Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy
- NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia
- Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia
- Maternal flow-mediated dilation and nitrite concentration during third trimester of pregnancy and postpartum period
- Maternal iNOS genetic polymorphisms and hypertensive disorders of pregnancy
- Predição de pré-eclâmpsia [Editorial]
Informações sobre o DOI: 10.1111/j.1742-7843.2012.00905.x (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
